Status:
COMPLETED
Absolute Quantification in Bone Scintigraphy
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Scintigraphy Quantification
Eligibility:
All Genders
18+ years
Brief Summary
While absolute quantification in 18F-FDG PET (Positon Emission Tomography) is widely used in clinical routine, absolute quantification in SPECT (Single Photon Emission Computed Tomography) is under de...
Detailed Description
In oncology, bone scan studies have reported significantly higher SUV values for secondary bone lesions compared with benign osteoarticular lesions , and some have even defined an SUVmax threshold val...
Eligibility Criteria
Inclusion
- Patients with recent vertebral fractures:
- who have had at least two SPECT/CT scan scans of the spine as part of a pre-vertebroplasty check-up,
- for which fracture dates were known.
Exclusion
- Minor person
- Person opposing the use of their data (Posters in waiting rooms explaining that the patient must object if they do not wish their data to be used)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04671238
Start Date
January 1 2020
End Date
February 1 2021
Last Update
September 13 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nancy - Hôpital Brabois
Vandœuvre-lès-Nancy, France, 54500
2
Chru Nancy
Vandœuvre-lès-Nancy, France, 54511
3
CHRU of Nancy
Vandœuvre-lès-Nancy, France, 54511